TITLE

Stem cells: Sweetening pluripotency

AUTHOR(S)
Donner, Amy
PUB. DATE
July 2012
SOURCE
Nature Chemical Biology;Jul2012, Vol. 8 Issue 7, p602
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information on the transformation of somatic cells into induced pluripotent stem cells by the combination of transcription factors which includes octamer binding transcription factor 4 (OCT-4) and SOX2.
ACCESSION #
76639742

 

Related Articles

  • Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective. Liang, Gaoyang; Zhang, Yi // Cell Research;Jan2013, Vol. 23 Issue 1, p49 

    Pluripotent stem cells, like embryonic stem cells (ESCs), have specialized epigenetic landscapes, which are important for pluripotency maintenance. Transcription factor-mediated generation of induced pluripotent stem cells (iPSCs) requires global change of somatic cell epigenetic status into an...

  • Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming. Liang, Gaoyang; He, Jin; Zhang, Yi // Nature Cell Biology;May2012, Vol. 14 Issue 5, p457 

    Transcription-factor-directed reprogramming from somatic cells to induced pluripotent stem cells (iPSCs) is by nature an epigenetic process of cell fate change. Previous studies have demonstrated that this inefficient process can be facilitated by the inclusion of additional factors. To gain...

  • The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming. Mansour, Abed AlFatah; Gafni, Ohad; Weinberger, Leehee; Zviran, Asaf; Ayyash, Muneef; Rais, Yoach; Krupalnik, Vladislav; Zerbib, Mirie; Amann-Zalcenstein, Daniela; Maza, Itay; Geula, Shay; Viukov, Sergey; Holtzman, Liad; Pribluda, Ariel; Canaani, Eli; Horn-Saban, Shirley; Amit, Ido; Novershtern, Noa; Hanna, Jacob H. // Nature;8/16/2012, Vol. 488 Issue 7411, p409 

    Induced pluripotent stem cells (iPSCs) can be derived from somatic cells by ectopic expression of different transcription factors, classically Oct4 (also known as Pou5f1), Sox2, Klf4 and Myc (abbreviated as OSKM). This process is accompanied by genome-wide epigenetic changes, but how these...

  • Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors. Maza, Itay; Caspi, Inbal; Zviran, Asaf; Chomsky, Elad; Rais, Yoach; Viukov, Sergey; Geula, Shay; Buenrostro, Jason D; Weinberger, Leehee; Krupalnik, Vladislav; Hanna, Suhair; Zerbib, Mirie; Dutton, James R; Greenleaf, William J; Massarwa, Rada; Novershtern, Noa; Hanna, Jacob H // Nature Biotechnology;Jul2015, Vol. 33 Issue 7, p769 

    Somatic cells can be transdifferentiated to other cell types without passing through a pluripotent state by ectopic expression of appropriate transcription factors. Recent reports have proposed an alternative transdifferentiation method in which fibroblasts are directly converted to various...

  • An Insight into Reprogramming Barriers to iPSC Generation. Haridhasapavalan, Krishna Kumar; Raina, Khyati; Dey, Chandrima; Adhikari, Poulomi; Thummer, Rajkumar P. // Stem Cell Reviews & Reports;Feb2020, Vol. 16 Issue 1, p56 

    Derivation of induced Pluripotent Stem Cells (iPSCs) by reprogramming somatic cells to a pluripotent state has revolutionized stem cell research. Ensuing this, various groups have used genetic and non-genetic approaches to generate iPSCs from numerous cell types. However, achieving a pluripotent...

  • Zfp296 Is a Novel, Pluripotent-Specific Reprogramming Factor. Fischedick, Gerrit; Klein, Diana C.; Wu, Guangming; Esch, Daniel; Höing, Susanne; Han, Dong Wook; Reinhardt, Peter; Hergarten, Kerstin; Tapia, Natalia; Schöler, Hans R.; Sterneckert, Jared L. // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Expression of the four transcription factors Oct4, Sox2, Klf4, and c-Myc (OSKM) is sufficient to reprogram somatic cells into induced pluripotent stem (iPSCs). However, this process is slow and inefficient compared with the fusion of somatic cells with embryonic stem cells (ESCs), indicating...

  • Experimental approaches for the generation of induced pluripotent stem cells. Sommer, Cesar A.; Mostoslavsky, Gustavo // Stem Cell Research & Therapy;2010, Vol. 1 Issue 3, p1 

    Derivation of autologous induced pluripotent stem cells (iPSCs) through direct reprogramming of easily accessible somatic cells holds the potential to transform the field of regenerative medicine. Since Takahashi and Yamanaka's groundbreaking study describing the generation of iPSCs by...

  • Notch inhibition allows oncogene-independent generation of iPS cells. Ichida, Justin K; T C W, Julia; Williams, Luis A; Carter, Ava C; Shi, Yingxiao; Moura, Marcelo T; Ziller, Michael; Singh, Sean; Amabile, Giovanni; Bock, Christoph; Umezawa, Akihiro; Rubin, Lee L; Bradner, James E; Akutsu, Hidenori; Meissner, Alexander; Eggan, Kevin // Nature Chemical Biology;Aug2014, Vol. 10 Issue 8, p632 

    The reprogramming of somatic cells to pluripotency using defined transcription factors holds great promise for biomedicine. However, human reprogramming remains inefficient and relies either on the use of the potentially dangerous oncogenes KLF4 and CMYC or the genetic inhibition of the tumor...

  • Induced pluripotent stem cells in research and therapy. Hoon-Koon Teoh; Soon-Keng Cheong // Malaysian Journal of Pathology;Jun2012, Vol. 34 Issue 1, p1 

    Induced pluripotent stem cells (iPSC) are derived from human somatic cells through ectopic expression of transcription factors. This landmark discovery has been considered as a major development towards patient-specific iPSC for various biomedical applications. Unlimited self renewal capacity,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics